The earnings call summary and Q&A section indicate positive sentiment overall. Strong product launches and business updates, such as Tryptyr and Unity, are expected to drive growth. While there are challenges in international markets like China, management is confident about their strategies. The guidance for 2026 suggests optimism, with potential outperformance from new products. Despite some uncertainties in the IOL market, the company's focus on innovation and expanding its portfolio supports a positive outlook. The stock is likely to see a positive movement in the next two weeks, given these factors.